CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,179,093
- in 16 filings, $36.7M under 10b5-1 plans
Net −$41,179,093. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +1,100 | $14.08 | $15K | 1,100 |
| 2026-11-10 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +400 | $10.50 | $4K | 1,500 |
| 2026-11-10 | Swisher Daniel N JR Director | Sale 10b5-1 | −1,500 | $74.07 | $111K | 0 |
| 2026-11-10 | Swisher Daniel N JR Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,100 | 0 | ||
| 2026-11-10 | Swisher Daniel N JR Director | Option exercise · Stock Option (right to buy) 10b5-1 | −400 | 12,100 | ||
| 2026-11-03 | Maduck Sean See Remarks | Option exercise 10b5-1 | +13,159 | $8.27 | $109K | 23,097 |
| 2026-11-03 | Maduck Sean See Remarks | Sale 10b5-1 | −8,617 | $82.02 | $707K | 14,480 |
| 2026-11-03 | Maduck Sean See Remarks | Sale 10b5-1 | −4,542 | $82.68 | $376K | 9,938 |
| 2026-11-03 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −13,159 | 16,986 | ||
| 2026-11-02 | Maduck Sean See Remarks | Option exercise 10b5-1 | +11,841 | $8.27 | $98K | 21,779 |
| 2026-11-02 | Maduck Sean See Remarks | Sale 10b5-1 | −11,841 | $81.42 | $964K | 9,938 |
| 2026-11-02 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −11,841 | 30,145 | ||
| 2026-11-02 | Vieira Roberto Wandenkolk President, Oncology | Option exercise 10b5-1 | +8,333 | $21.63 | $180K | 12,279 |
| 2026-11-02 | Vieira Roberto Wandenkolk President, Oncology | Sale 10b5-1 | −6,657 | $80.73 | $537K | 5,622 |
| 2026-11-02 | Vieira Roberto Wandenkolk President, Oncology | Sale 10b5-1 | −1,676 | $81.52 | $137K | 3,946 |
| 2026-11-02 | Vieira Roberto Wandenkolk President, Oncology | Option exercise · Stock option (right to buy) 10b5-1 | −8,333 | 125,001 | ||
| 2026-10-15 | WILSON JAMES N Director | Sale 10b5-1 | −6,654 | $114.48 | $762K | 1,057,889 |
| 2026-10-15 | WILSON JAMES N Director | Sale 10b5-1 | −3,046 | $115.39 | $351K | 1,054,843 |
| 2026-10-15 | WILSON JAMES N Director | Sale 10b5-1 | −300 | $116.30 | $35K | 1,054,543 |
| 2026-10-02 | Vieira Roberto Wandenkolk President, Oncology | Option exercise 10b5-1 | +8,333 | $21.63 | $180K | 12,279 |
Page 1 of 62 · 1,225 trades